Voglistar GM2 Tab — Uses, Dosage & Benefits

Voglibose 0.2 mg + Metformin Hydrochloride 500 mg (as sustained release) + Glimepiride 2 mg

Voglibose inhibits intestinal alpha‑glucosidase enzymes, delaying carbohydrate digestion and reducing post‑meal blood glucose spikes. Metformin decreases hepatic glucose production and improves insulin sensitivity. Glimepiride stimulates insulin release from pancreatic beta cells to lower blood glucose.

Tablet (oral). Take exactly as prescribed, usually once daily with the first main meal; swallow whole with water (do not crush/chew as it contains sustained‑release metformin). Follow diet/exercise advice and monitor blood glucose regularly.

Always follow your doctor's prescription. Do not self-medicate.